WF6 logo

MindBio Therapeutics DB:WF6 Stock Report

Last Price

€0.007

Market Cap

€2.3m

7D

0%

1Y

-51.4%

Updated

24 Nov, 2024

Data

Company Financials

MindBio Therapeutics Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MindBio Therapeutics
Historical stock prices
Current Share PriceCA$0.007
52 Week HighCA$0.06
52 Week LowCA$0.007
Beta0
11 Month Change-64.65%
3 Month Change-33.96%
1 Year Change-51.39%
33 Year Changen/a
5 Year Changen/a
Change since IPO-90.54%

Recent News & Updates

Recent updates

Shareholder Returns

WF6DE PharmaceuticalsDE Market
7D0%-1.2%-0.02%
1Y-51.4%-20.1%8.2%

Return vs Industry: WF6 underperformed the German Pharmaceuticals industry which returned -22% over the past year.

Return vs Market: WF6 underperformed the German Market which returned 7.4% over the past year.

Price Volatility

Is WF6's price volatile compared to industry and market?
WF6 volatility
WF6 Average Weekly Movement105.5%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.3%

Stable Share Price: WF6's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: WF6's weekly volatility has increased from 67% to 105% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021n/aJustin Hankawww.mindbiotherapeutics.com

MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated via digital therapeutic platforms; and invests in research for developing treatments for depression, anxiety, PTSD and chronic pain.

MindBio Therapeutics Corp. Fundamentals Summary

How do MindBio Therapeutics's earnings and revenue compare to its market cap?
WF6 fundamental statistics
Market cap€2.32m
Earnings (TTM)-€170.80k
Revenue (TTM)n/a

0.0x

P/S Ratio

-13.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WF6 income statement (TTM)
RevenueAU$0
Cost of RevenueAU$0
Gross ProfitAU$0
Other ExpensesAU$273.69k
Earnings-AU$273.69k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.002
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-84.8%

How did WF6 perform over the long term?

See historical performance and comparison